Gene Editing
Overview
R&D Platforms
Manufacturing
Papers & Presentations
Our Pipeline
Our Pipeline
Ex Vivo Therapies
In Vivo Therapies
Targeted Therapies
Our Focus
Genetic Diseases
Cancer
About Us
Company Overview
Scientific Founder
Leadership
Contact Us
Careers
Join Us
News
Press Releases
In the Media
简体中文
中文
GENOME EDITING
FOR A BETTER LIFE
Press Releases
In the Media
>
News
>
Press Releases
Press Releases
All
2020
2019
2018
Search
27
2020-10
EdiGene Announces IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia Accepted for Review by China National Medical Products Administration
LEARN MORE
13
2020-10
EdiGene Raises Approximately USD 67 Million in Series B Financing to Advance Gene Editing Based Programs into Clinical Stage
LEARN MORE
27
2020-05
EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer
LEARN MORE
30
2020-04
EdiGene to Present Data on its Lead RNA Base Editing Program to Treat Patients with the Most Severe Form of MPS I
LEARN MORE
21
2019-11
EdiGene to Present Data on Manufacturing Scale-up and Preclinical Development of its Leading Gene Editing Therapeutic Program to Treat Patients with β-Thalassemia Major
LEARN MORE
17
2019-09
Genome Editing Biotech EdiGene Raises $11 M in Series Pre-B2 Financing and Forms Research Collaboration to Develop Allogeneic T-cell Therapeutics for Cancer
LEARN MORE
12
2019-08
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio
LEARN MORE
18
2019-07
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
LEARN MORE
03
2019-04
EdiGene Announced Strategic Collaboration with Genetron
LEARN MORE
26
2019-02
Genome Editing Biotech EdiGene Raises $10 Million in Series pre-B Plus Financing and Strengthens Management Team
LEARN MORE
1
2
